Pharma On Its Back Foot As US Drug Price Reform Advances

 
• By Jessica Merrill

Big pharma leaders warn of steep cuts to R&D and US jobs if US drug pricing reform legislation paves the way for direct government price negotiations.

Defense Goal
The pharma industry mounts a defense on US drug pricing • Source: Alamy

More from Pricing Debate

More from Market Access